Cargando…

Angiotensin-converting enzyme inhibitor reduces scar formation by inhibiting both canonical and noncanonical TGF-β1 pathways

Angiotensin-converting enzyme inhibitors (ACEIs) can improve the fibrotic processes in many internal organs. Recent studies have shown a relationship between ACEI with cutaneous scar formation, although it has not been confirmed, and the underlying mechanism is unclear. In this study, we cultured mo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fang, Qing-Qing, Wang, Xiao-Feng, Zhao, Wan-Yi, Ding, Shi-Li, Shi, Bang-Hui, Xia, Ying, Yang, Hu, Wu, Li-Hong, Li, Cai-Yun, Tan, Wei-Qiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5820264/ https://www.ncbi.nlm.nih.gov/pubmed/29463869 http://dx.doi.org/10.1038/s41598-018-21600-w

Ejemplares similares

The compound losartan cream inhibits scar formation via TGF-β/Smad pathway
por: Zhao, Wan-Yi, et al.
Publicado: (2022)

Angiotensin-Converting Enzyme Inhibitor, Captopril, Improves Scar Healing in Hypertensive Rats
por: Rha, Eun Young, et al.
Publicado: (2021)

Angiotensin Converting Enzymes
por: Wong, Marty K.S.
Publicado: (2016)

Angiotensin converting enzyme
por: Wong, Marty Kwok-Shing
Publicado: (2021)

Angiotensin converting enzymes inhibitors or angiotensin receptor blockers should be continued in COVID-19 patients with hypertension
por: Tian, Ci, et al.
Publicado: (2021)

Canonical and noncanonical TGF-β signaling regulate fibrous tissue differentiation in the axial skeleton
por: Clayton, Sade W., et al.
Publicado: (2020)

Angiotensin-Converting Enzyme-2
por: Clarke, Nicola E., et al.
Publicado: (2013)

Angiotensin-converting enzyme activity and inhibition in dogs with cardiac disease and an angiotensin-converting enzyme polymorphism
por: Meurs, Kathryn M, et al.
Publicado: (2017)

Dietary Potassium Downregulates Angiotensin-I Converting Enzyme, Renin, and Angiotensin Converting Enzyme 2
por: Vio, Carlos P., et al.
Publicado: (2020)

Re-evaluating serum angiotensin-converting enzyme in sarcoidosis
por: Zheng, Shi-yue, et al.
Publicado: (2023)

Changes of Plasma Angiotensin-Converting Enzyme Activity during Hemodialysis(*)
por: Koo, Wan Suh, et al.
Publicado: (1987)

Co-transfection of hepatocyte growth factor and truncated TGF-β type II receptor inhibit scar formation
por: Xu, Ji-Hua, et al.
Publicado: (2020)

Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 2019
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2020)

HTR1A Inhibits the Progression of Triple‐Negative Breast Cancer via TGF‐β Canonical and Noncanonical Pathways
por: Liu, Qiqi, et al.
Publicado: (2022)

Effect of telmisartan, angiotensin‐converting enzyme inhibition, or both, on proteinuria and blood pressure in dogs
por: Fowler, Brittany L., et al.
Publicado: (2021)

WNT-3A modulates articular chondrocyte phenotype by activating both canonical and noncanonical pathways
por: Nalesso, Giovanna, et al.
Publicado: (2011)

Angiotensin-Converting Enzyme 2 and the Resolution of Inflammation: In Support of Continuation of Prescribed Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers
por: Gersh, Felice L.
Publicado: (2020)

Effects of angiotensin receptor blockers and angiotensin-converting enzyme inhibitors on COVID-19
por: Li, Xiao-Long, et al.
Publicado: (2021)

Angiotensin-Converting Enzyme Inhibitors and Angioedema
por: Sánchez-Borges, Mario, et al.
Publicado: (2010)

Angiotensin-converting Enzyme Genetic Polymorphism
por: Wiwanitkit, Somsri, et al.
Publicado: (2014)

Potential angiotensin converting enzyme (ACE) inhibitors from Iranian traditional plants described by Avicenna’s Canon of Medicine
por: Kamrani Rad, Seyede Zohre, et al.
Publicado: (2019)

Formation and inhibition mechanism of novel angiotensin I converting enzyme inhibitory peptides from Chouguiyu
por: Yang, Daqiao, et al.
Publicado: (2022)

Features and mechanisms of canonical and noncanonical genomic imprinting
por: Hanna, Courtney W., et al.
Publicado: (2021)

In reply—Angiotensin-Converting Enzyme 2 and the Resolution of Inflammation: In Support of Continuation of Prescribed Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2020)

Renin‐angiotensin aldosterone profile before and after angiotensin‐converting enzyme‐inhibitor administration in dogs with angiotensin‐converting enzyme gene polymorphism
por: Adin, Darcy, et al.
Publicado: (2020)

The Influence of Angiotensin Converting Enzyme and Angiotensinogen Gene Polymorphisms on Hypertrophic Cardiomyopathy
por: Luo, Rong, et al.
Publicado: (2013)

Angiotensin-converting enzyme gene variants are associated with both cortisol secretion and late-life depression
por: Ancelin, M-L, et al.
Publicado: (2013)

Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Rescue Memory Defects in Drosophila-Expressing Alzheimer’s Disease-Related Transgenes Independently of the Canonical Renin Angiotensin System
por: Lee, Shin-Hann, et al.
Publicado: (2020)

Intrarenal Distributions and Changes of Angiotensin-Converting Enzyme and Angiotensin-Converting Enzyme 2 in Feline and Canine Chronic Kidney Disease
por: MITANI, Sawane, et al.
Publicado: (2013)

Salt Restriction and Angiotensin-Converting Enzyme Inhibitor Improve the Responsiveness of the Small Artery in Salt-Sensitive Hypertension
por: Li, Shi-Cheng, et al.
Publicado: (2023)

Discovery and biosynthesis of karnamicins as angiotensin converting enzyme inhibitors
por: Yu, Zhiyin, et al.
Publicado: (2023)

Angiotensin-converting enzyme defines matrikine-regulated inflammation and fibrosis
por: O’Reilly, Philip J., et al.
Publicado: (2017)

Angiotensin-converting enzyme polymorphisms AND Alzheimer’s disease susceptibility: An updated meta-analysis
por: Xin, Xiao-Yu, et al.
Publicado: (2021)

Angiotensin-converting enzyme 2/angiotensin-(1–7)/Mas axis activates Akt signaling to ameliorate hepatic steatosis
por: Cao, Xi, et al.
Publicado: (2016)

Angiotensin-Converting Enzyme 2: The First Decade
por: Clarke, Nicola E., et al.
Publicado: (2012)

Angiotensin-I-converting enzyme and its relatives
por: Riordan, James F
Publicado: (2003)

Serum Angiotensin Converting Enzyme in Pemphigus Vulgaris
por: Robati, Reza M, et al.
Publicado: (2014)

Angiotensin Converting Enzyme Activity in Alopecia Areata
por: Namazi, Mohammad Reza, et al.
Publicado: (2014)

Angiotensin-converting enzyme 2 in lung diseases
por: Kuba, Keiji, et al.
Publicado: (2006)

Angiotensin converting enzyme polymorphism and ischemic stroke
por: Salem, Gelan M., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_uhgnfbvc1aqq42bvhooir4opd2